Successful pharmaceutical discovery: Paul Janssen's concept of drug research

R and D Management

Volumn 37, Issue 4, 2007, Pages 355-362

  Lewi, Paul J ^a,b   Smith, Adam ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Nobel Web AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548430961     PISSN: 00336807     EISSN: 14679310     Source Type: Journal    
DOI: 10.1111/j.1467-9310.2007.00481.x     Document Type: Article

References (27)

1. Black, J. (2005) Dr. Paul Janssen. Journal of Medicinal Chemistry, 48, 1687 1688.
2. Brown, P. (2003) Of dinosaurs and drugs. Scrip Magazine, January, pp. 3 6.
3. Cech, T.R. Rubin, G.M. (2004) Nurturing interdisciplinary research. Nature Structural & Molecular Biology, 11, 1166 1169.
4. Clarke, D.E. (1997) Drug discovery: some directional pointers. Trends in Pharmacological Sciences, 18, 19 20.
5. Cuatrecasas, P. (2006) Drug discovery in jeopardy. The Journal of Clinical Investigation, 116, 2837 2842.
6. Goleman, D., Boyatzis, R. McKee, A. (2001) Primal leadership: the hidden driver of great performance. Harvard Business Review, 79, 43 51.
7. Healy, D. (1998) Paul Janssen (Belgium). From Haloperidol to Risperidone. In Healy, D. (ed.), The Psychopharmacologists II. London : Chapman & Hall, pp. 39 68.
8. Horrobin, D.F. (2003) Modern biomedical research: an internally self-consistent universe with little contact with medical reality? Nature Reviews Drug Discovery, 2, 151 154.
9. Hughes, S. (1993) An unconventional approach to research. Scrip Magazine, January, pp. 32 33.
10. Janssen, P.A.J. (1970) The Butyrophenone story. In Ayd, F.J. Blackwell, B. (eds), Discoveries in Biological Psychiatry. Philadelphia, PA : Lipincott, pp. 165 169.
11. Janssen, P.A.J. (1980) Drug research. Revue Médicale de Bruxelles, 1, 643 645.
12. Janssen, P.A.J. (1981) The four pillars of effective drug research. Clinical Research Reviews, 1, 87 89.
13. Kubinyi, H. (1999) Chance favors the prepared mind - from serendipity to rational drug design. Journal of Receptors and Signal Transduction, 19, 15 39.
14. Kubinyi, H. (2003) Drug research: myths, hype and reality. Nature Reviews Drug Discovery, 2, 665 667.
15. Lewi, P.J. (2004) Obituary Dr. Paul Janssen (1926-2003). European Journal of Neuropsychopharmacology, 14, 353.
16. Lewi, P.J. (2005) The role of statistics in the success of a pharmaceutical research laboratory: a historical case description. Journal of Chemometrics, 19, 282 287.
17. McGregor, D. (1960) The Human Side of Enterprise. New York : McGraw-Hill.
18. Reyntjens, A. Van Reet, S. (1991) Success factors of Janssen research. Drug News and Perspectives, 4, 185 190.
19. Schwartz, H. (1989) Breakthrough. The Discovery of Modern Medicines at Janssen. Morris Plains, NJ : Skyline Publishing Group.
20. Smith, A. (2002) Fuelling the pipeline. Nature Reviews Drug Discovery, 1, 167.
21. Smith, A. (2003) A call to arms for drug discoverers. Nature Reviews Drug Discovery, 2, 335.
22. Smith, A. (2004) The conductorless orchestra. Nature Reviews Drug Discovery, 3, 3.
23. Uitdehaag, J.C. (2007) Where is the optimism? Warrior teachings to regain the drug discovery spirit. Drug Discovery Today, 12, 105 107.
24. Van Gestel, S. Schuermans, V. (1986) Thirty-three years of drug discovery and research with Dr. Paul Janssen. Drug Development Research, 8, 1 13.
25. Vojak, B.A., Griffin, A., Price, R.L. Perlov, K. (2006) Characteristics of technical visionaries as perceived by American and British physicists. R&D Management, 36, 17 26.
26. Weisbach, J.A. Moos, W.H. (1995) Diagnosing the decline of major pharmaceutical research laboratories: a prescription for drug companies. Drug Development Research, 34, 243 259.
27. Williams, M. (2004) A return to the fundamentals of drug discovery? Current Opinion in Investigational New Drugs, 5, 29 33.